Newsroom-Katalog
Zeit | Boehringer Ingelheim: Meldungen vom 01.11.2004 |
---|---|
14:11 | Boehringer Ingelheim Announces 24-Week Interim Results from Tipranavir RESIST-1 Phase 3 Study |
Zeit | Boehringer Ingelheim: Meldungen vom 01.11.2004 |
---|---|
14:11 | Boehringer Ingelheim Announces 24-Week Interim Results from Tipranavir RESIST-1 Phase 3 Study |